{"id":"https://openalex.org/keywords/ozanimod","display_name":"ozanimod","description":"Ozanimod is an oral sphingosine 1-phosphate receptor modulator used to treat relapsing multiple sclerosis and ulcerative colitis.","display_name_alternatives":["RPC1063","RPC-1063","Zeposia"],"ids":{"openalex":"https://openalex.org/keywords/ozanimod","wikidata":"https://www.wikidata.org/wiki/Q21098986"},"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.4439,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.4439,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.2692,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.0738,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"works_count":819,"cited_by_count":11193,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/ozanimod","updated_date":"2026-11-18T04:07:20","created_date":"2022-04-12T19:38:12"}
